Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.
about
Metabolomics reveals amino acids contribute to variation in response to simvastatin treatmentUtility of mass spectrometry for the diagnosis of the unstable coronary plaqueEmerging protein array technologies for proteomicsApplications of targeted proteomics in systems biology and translational medicineTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsProteolysis controls endogenous substance P levelsDesign, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)Elective affinities--bioinformatic analysis of proteomic mass spectrometry data.Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysisSampling the N-terminal proteome of human blood.Stable-isotope dilution LC–MS for quantitative biomarker analysis.Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjectsProteogenomic convergence for understanding cancer pathways and networks.Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.mProphet: automated data processing and statistical validation for large-scale SRM experiments.The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategiesSRMBuilder: a user-friendly tool for selected reaction monitoring data analysis.Quantitative proteomics in cardiovascular research: global and targeted strategiesMulti-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer modelAn assessment of current bioinformatic solutions for analyzing LC-MS data acquired by selected reaction monitoring technology.Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.Synthetic peptide arrays for pathway-level protein monitoring by liquid chromatography-tandem mass spectrometry.Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.Stable isotope imaging of biological samples with high resolution secondary ion mass spectrometry and complementary techniques.Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics.Improved detection specificity for plasma proteins by targeting cysteine-containing peptides with photo-SRM.The sweet and sour of serological glycoprotein tumor biomarker quantification.Index-ion triggered MS2 ion quantification: a novel proteomics approach for reproducible detection and quantification of targeted proteins in complex mixtures.Targeted quantitation of proteins by mass spectrometry.Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry.Quantification of activated NF-kappaB/RelA complexes using ssDNA aptamer affinity-stable isotope dilution-selected reaction monitoring-mass spectrometryAutomated sample preparation platform for mass spectrometry-based plasma proteomics and biomarker discoveryRapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring.A targeted proteomics-based pipeline for verification of biomarkers in plasma18O-labeled proteome reference as global internal standards for targeted quantification by selected reaction monitoring-mass spectrometry.
P2860
Q21561017-9C500982-3397-41E4-92E9-A62592F9AC46Q26780282-59FA9026-CC27-4BAD-9AB0-D0D2956ACA34Q26824107-DBC44925-10CF-4F70-A79C-B43BE0E98036Q26852271-1614B992-6059-4362-8A2F-9CE309109A0CQ28085015-AE663F95-4E21-4B58-8178-EB52569C07D2Q28534739-AB89DA5E-ECED-4268-84F3-A74E14DBF2C5Q28681060-DD352641-D620-4234-9E78-D79EC4B1F7DDQ33515901-E83B78E5-857D-4324-B395-1DE66CDADC8CQ33718710-B7963C34-076B-466D-9F29-826B186C340AQ33740667-E283C22E-E634-45E7-AEB4-5589237AEF6AQ33747062-6EC1A0B5-21C8-4172-9D5B-783960D95019Q33775524-A5EBEC5E-6119-42D7-AEB7-37DEDE0B2BF8Q33784462-E446F53F-1550-43AF-8785-EF72637FBFF0Q33792433-85BE61C4-3B10-4FEE-8FCC-96671052001BQ33797033-9680BE41-FED7-478E-A593-183A0E323C0AQ33851184-D67120C4-7EDC-47F4-8BCD-CB839CE3531AQ33897503-5BC4CAAC-0F42-4A5E-8B5E-C5F551DEA392Q34092297-A00F8DFB-3F57-41AD-8B85-86459B244AA6Q34156082-320C128D-CE67-4FF1-9B30-3F3CAAEC56A0Q34180244-61E89AAB-BFBF-4284-9F42-5BA061CFCC2EQ34265969-2AC0C8FA-CD4A-4C9A-BAC8-715C3C165974Q34268925-6B211F17-3A73-4146-9182-6D49D5F058B1Q34283031-C7334F24-84F8-49C1-ACD5-62E69A2F2E81Q34320740-24B7FF96-D0AB-44B5-BA4F-F247BF6CA22BQ34359998-1FAA9E50-F5FA-4FEF-9E08-4028957AF617Q34421676-95E2F22E-C89D-4DFD-AC78-5266CB2B598CQ34463873-ABBD846D-E79A-4BD5-8A1A-BF08E86C2D93Q34487045-2F6CF5BA-B5A1-4B79-A06B-ECBB027E4B54Q34550436-D92023A4-A4FD-4654-96CB-1E746AB4AA5EQ34580285-6B5E38A4-15E6-45F9-AF52-36B8912306C7Q34616855-3BD8102D-56BA-472E-AF52-19A8834B7D87Q34630866-191E77AA-7F5E-42B9-BCDC-89800C3E5BD1Q34751690-C5869073-A7DC-4994-923E-BA660E8C7E0AQ34754750-5E2C388D-EB02-4EF9-A2D9-21B98B3C6F9BQ35026899-6BD2EE1F-B4B0-49B2-85B3-E570AC483CE8Q35026929-D5FD6C38-1D8F-432A-BABC-82577A55DC64Q35169652-16C87E99-6141-4C8A-9A5A-36D51EC7700EQ35194600-052AD2B2-2782-4D04-99CC-3A0737078127Q35596338-7ACE5524-E0DD-4638-ACBE-7842012EA99AQ35610629-378CA86A-9809-440E-A122-BB386A6BFCCE
P2860
Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantification of cardiovascul ...... y and stable isotope dilution.
@en
Quantification of cardiovascul ...... y and stable isotope dilution.
@nl
type
label
Quantification of cardiovascul ...... y and stable isotope dilution.
@en
Quantification of cardiovascul ...... y and stable isotope dilution.
@nl
prefLabel
Quantification of cardiovascul ...... y and stable isotope dilution.
@en
Quantification of cardiovascul ...... y and stable isotope dilution.
@nl
P2093
P2860
P921
P1476
Quantification of cardiovascul ...... ry and stable isotope dilution
@en
P2093
Hasmik Keshishian
Marc S Sabatine
Michael Burgess
Robert E Gerszten
Steven A Carr
Terri Addona
P2860
P304
P356
10.1074/MCP.M900140-MCP200
P50
P577
2009-07-13T00:00:00Z